Everyday medicines can destroy lives, conference warns

Updated on - Written by

Delegates at an international conference heard that more needed to be done to raise the profile of the Yellow Card scheme, which allows patients to directly report serious side effects of prescribed medicines that have not previously been included in pharmaceutical product literature.

It followed recent research led by academics at The University of Nottingham, University of Aberdeen, the Drug Safety Research Unit (DSRU) and Liverpool John Moores University which showed that patient reporting of suspected adverse drugs reactions, or ADRs, through the Yellow Card scheme is richer in detail and better at describing the impact on their daily lives than information supplied by health care professionals.

Click here for full story

Story credits

More information is available from Professor Tony Avery on +44 (0)7976 129622, [email protected] or Professor Janet Krska on +44 (0)151 231 2404, [email protected]

Emma Thorne

Emma Thorne – Media Relations Manager

Email: [email protected] Phone: +44 (0)115 951 5793 Location: King’s Meadow Campus


+ sources

Health Canal avoids using tertiary references. We have strict sourcing guidelines and rely on peer-reviewed studies, academic researches from medical associations and institutions. To ensure the accuracy of articles in Health Canal, you can read more about the editorial process here

Written by:

Healthcanal Staff

Medically reviewed by:

HealthCanal Editorial team is a team of high standard writers, who qualified the strict entrance test of Health Canal. The team involves in both topic researching and writting, which are under supervision and controlled by medical doctors of medical team.

PubMed Central

Database From National Institute Of Health

U.S National Library of Medicine
Go to source